Contribution of imidazoline receptors and α2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine
Geoffrey Head
Journal of Hypertension, 2007
View PDFchevron_right
Relationship between imidazoline and α2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents
Geoffrey Head
Journal of the Autonomic Nervous System, 1998
View PDFchevron_right
Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex
Bela Szabo
British Journal of Pharmacology, 2001
View PDFchevron_right
Central Imidazoline Receptors and Centrally Acting Anti-Hypertensive Agents
Geoffrey Head
Clinical and Experimental Hypertension, 1997
View PDFchevron_right
Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits
Geoffrey Head
Journal of Hypertension, 2003
View PDFchevron_right
Importance of Imidazoline Receptors in the Cardiovascular Actions of Centrally Acting Antihypertensive Agents
Geoffrey Head
Annals of the New York Academy of Sciences, 1995
View PDFchevron_right
Imidazoline Receptors but Not 2-Adrenoceptors Are Regulated in Spontaneously Hypertensive Rat Heart by Chronic Moxonidine Treatment
Suhayla Mukaddam-Daher
Journal of Pharmacology and Experimental Therapeutics, 2004
View PDFchevron_right
Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats
David Centurión
Autonomic Neuroscience, 2008
View PDFchevron_right
Imidazoline Receptors but Not α2-Adrenoceptors Are Regulated in Spontaneously Hypertensive Rat Heart by Chronic Moxonidine Treatment
Suhayla Mukaddam-Daher
Journal of Pharmacology and Experimental Therapeutics, 2004
View PDFchevron_right
Role of imidazoline receptors in cardiovascular regulation
H. Greney
The American Journal of Cardiology, 1994
View PDFchevron_right
Respective contributions of α-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs
Monique Dontenwill
British Journal of Pharmacology, 2001
View PDFchevron_right
A novel mechanism of action for hypertension control: Moxonidine as a selective I 1-imidazoline agonist
Paul Ernsberger
… drugs and therapy, 1994
View PDFchevron_right
Imidazoline antihypertensive drugs: a critical review on their mechanism of action
Bela Szabo
Pharmacology & Therapeutics, 2002
View PDFchevron_right
Imidazoline receptors of the paraventricular nucleus on the pressor response induced by stimulation of the subfornical organ
Eduardo Nogueira
Journal of Physiology-paris, 1998
View PDFchevron_right
Involvement of central α 1- and α 2-adrenoceptors on cardiovascular responses to moxonidine
Thiago Moreira
European Journal of Pharmacology, 2007
View PDFchevron_right
Relevance of the use of [3H]-clonidine to identify imidazoline receptors in the rabbit brainstem
H. Greney
British Journal of Pharmacology, 1993
View PDFchevron_right
Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats
Benjamin Gomez, Luis Enrique Cobos Puc, David Centurión
European Journal of Pharmacology, 2009
View PDFchevron_right
Chronic imidazoline receptor activation in spontaneously hypertensive rats
Suhayla Mukaddam-Daher
2002
View PDFchevron_right
Low dose of moxonidine within the rostral ventrolateral medulla improves the baroreflex sensitivity control of sympathetic activity in hypertensive rat
Xin Ni
Acta Pharmacologica Sinica, 2009
View PDFchevron_right
Comparison of the baroreceptor–heart rate reflex effects of moxonidine, rilmenidine and clonidine in conscious rabbits
Geoffrey Head
Journal of the Autonomic Nervous System, 1998
View PDFchevron_right
Contribution of I1‐Imidazoline Receptors and α2
Heikki Karppanen
1996
View PDFchevron_right
I 1 -Imidazoline Receptors
Phong Nguyen
Annals of the New York Academy of Sciences, 1995
View PDFchevron_right
Responses of the Cardiovascular System of the Rat to Noradrenaline Infusions and Their Modification by Adrenoceptor Blocking Agents
R. Neame
British Journal of Pharmacology, 1977
View PDFchevron_right
Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304
Bela Szabo
European Journal of Pharmacology, 1995
View PDFchevron_right
I1 imidazoline receptors in cardiovascular regulation: the place of rilmenidine&ast
Geoffrey Head
American journal of hypertension, 2000
View PDFchevron_right
EFFECTS OF AMITRIPTYLINE, DESIPRAMINE AND MIANSERIN ON NORADRENERGIC TRANSMISSION IN THE RAT ISOLATED RIGHT VENTRICLE
Lynn Bradley
Journal of Autonomic Pharmacology, 1983
View PDFchevron_right
Cardiovascular pharmacology α 2A -adrenoceptors, but not nitric oxide, mediate the peripheral cardiac sympatho-inhibition of moxonidine
Luis Enrique Cobos Puc, David Centurión
View PDFchevron_right
I1 imidazoline receptors in cardiovascular regulation: the place of rilmenidine
Geoffrey Head
American journal of hypertension, 2000
View PDFchevron_right
Involvement of α2-adrenoceptors in the cardiovascular effects of moxonidine
Bela Szabo
European Journal of Pharmacology, 1995
View PDFchevron_right